2026-08-04Bullish
-8.96%24 hours changeReports revealed exploratory merger talks with Bristol Myers Squibb, raising investor concerns over potential organic growth dilution.
read the report →← every name covered
FTSE 100
AZN.L
AstraZeneca PLC
latest move
-8.96%
2026-08-04
5 sessions · 2026-07-09 → 2026-08-04 · avg 9.86% · largest 13.92%
AstraZeneca PLC is a global, science-led biopharmaceutical giant specializing in the research, development, and commercialization of prescription medicines.
Price history
stitched from the price window carried by each report
Every session it moved
newest first2026-08-03Bullish
-8.96%24 hours changeReports revealed preliminary merger talks with Bristol Myers Squibb, raising investor fears of growth dilution and patent risks.
read the report →2026-07-14Bullish
-13.92%weekly changeThe stock fell after Wainua failed to meet its primary efficacy endpoint in a Phase III trial for ATTR-CM.
read the report →2026-07-10Bullish
-11.22%weekly changeAstraZeneca stock fell after its Phase III trial for heart disease drug Wainua failed to meet its primary endpoint.
read the report →2026-07-09Bullish
-6.22%24 hours changeAstraZeneca's Phase III CARDIO-TTRansform trial for Wainua failed to meet its primary endpoint in ATTR-CM patients.
read the report →